Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study

Ahmad Basil Nasir, Yassine Kilani, Mohammad Aldiabat, Omar Abdelghany, Youssef Hafez, Nitin Desai, Mahmoud Y Madi, Francis G Wade · 2026

Read Metabolic risk and metabolic dysfunction–associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study by Ahmad Basil Nasir, Yassine Kilani, Mohammad Aldiabat, Omar Abdelghany, Youssef Hafez, Nitin Desai, Mahmoud Y Madi, Francis G Wade (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353160.txt.

Description

Nasir and colleagues asked whether fatty liver disease and metabolic risks track later thinking decline in a 2026 study. Records from dozens of American health organizations covered two decades. One matched comparison set pitted millions of adults with metabolic risks against healthy controls, and another compared liver patients with risk-only patients.

Outcomes included mild thinking impairment and two kinds of dementia, tracked after matching for age, sex, and background. People with prior brain disease or advanced liver disease were excluded to keep the question clean. If liver disease adds risk beyond shared metabolic factors, brain screening may belong in liver clinics.

Catalog record

CREATORAhmad Basil Nasir, Yassine Kilani, Mohammad Aldiabat, Omar Abdelghany, Youssef Hafez, Nitin Desai, Mahmoud Y Madi, Francis G Wade
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30201
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353160

Browse the full library · About the Tower of Babel